TetraLogic Pharmaceuticals Corporation
TLOG · OTC
9/30/2016 | 6/30/2016 | 3/31/2016 | 12/31/2015 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6 | $9 | $15 | $15 |
| Short-Term Investments | $0 | $0 | $0 | $5 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $1 | $1 | $2 |
| Total Curr. Assets | $6 | $9 | $16 | $22 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $36 | $42 | $42 | $42 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | -$0 | $0 | $0 | $0 |
| Total NC Assets | $36 | $42 | $42 | $42 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $43 | $51 | $58 | $64 |
| Liabilities | – | – | – | – |
| Payables | $0 | $1 | $2 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $13 | $11 | $3 | $3 |
| Total Curr. Liab. | $13 | $12 | $5 | $4 |
| LT Debt | $31 | $30 | $29 | $28 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $15 | $17 | $17 | $17 |
| Other NC Liab. | $15 | $15 | $40 | $21 |
| Total NC Liab. | $60 | $61 | $69 | $66 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | -$0 | -$0 | $0 | -$0 |
| Total Liabilities | $74 | $73 | $74 | $70 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$202 | -$193 | -$187 | -$176 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $171 | $171 | $171 | $170 |
| Total Equity | -$31 | -$22 | -$16 | -$6 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $43 | $51 | $58 | $64 |
| Net Debt | $25 | $21 | $15 | $13 |